CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
of up to 2 REACT injections given 3 months (+30 days) apart and delivered percutaneously into biopsied and non-biopsied contralateral kidneys...
Phase 3
Nashville, Tennessee, United States and 45 other locations
tolerability, and pharmacokinetics (PK) of VX-147 in adult and pediatric participants with apolipoprotein L1 (APOL1)-mediated proteinuric kidney...
Phase 2, Phase 3
Nashville, Tennessee, United States and 236 other locations
Primary Objective:Evaluate the effect of Hectorol® capsules in reducing elevated levels of intact parathyroid hormone (iPTH).Secondary Objectives:Eva...
Phase 3
Nashville, Tennessee, United States and 29 other locations
Researchers are looking for a better way to treat people who have non-diabetic chronic kidney disease (non-diabetic CKD). The trial ...
Phase 3
Nashville, Tennessee, United States and 312 other locations
The researchers are doing this study to see if semaglutide can slow down the growth and worsening of chronic kidney disease in peop...
Phase 3
Nashville, Tennessee, United States and 405 other locations
savolitinib, is effective in treating patients with MET-driven PRCC, how it compares with another medication frequently used to treat this disease...
Phase 3
Nashville, Tennessee, United States and 58 other locations
The purpose of this single-arm interventional study is to evaluate the long-term safety, efficacy, and durability of the Symplicity Spyral system in...
Nashville, Tennessee, United States and 81 other locations
The purpose of this study is to assess cognitive outcome and quality of life in stable renal transplant patients treated with twice daily tacrolimus...
Phase 4
Nashville, Tennessee, United States
or more. People can take part if they have cardiovascular or chronic kidney disease. People who have at least 2 health problems rel...
Phase 3
Nashville, Tennessee, United States and 491 other locations
by 5 years post-transplant ~10% of patients will have advanced renal disease that may require renal replacement therapy and/or kidney...
Early Phase 1
Nashville, Tennessee, United States
Clinical trials
Research sites
Resources
Legal